<DOC>
	<DOCNO>NCT01838499</DOCNO>
	<brief_summary>The purpose study gain initial evidence safety , tolerability efficacy MEDI8968 treatment subject moderate severe hidradenitis suppurativa</brief_summary>
	<brief_title>Assessment Safety , Tolerability Efficacy MEDI8968 Subjects With Moderate Severe Hidradenitis Suppurativa</brief_title>
	<detailed_description />
	<mesh_term>Hidradenitis</mesh_term>
	<mesh_term>Hidradenitis Suppurativa</mesh_term>
	<criteria>Hidradenitis suppurativa ( HS ) ( moderate severe ) Diagnosis HS least 1 year At least 5 active inflammatory lesion least 2 location On stable dose antibiotic and/or analgesic least 4 week ( already take medication ) Average pain score 39 . History cyclic neutropenia Laboratory assessment abnormality Underlying disorder consider unsuitable inclusion Other skin disease may interfere HS assessment Pregnancy planning pregnancy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>July 2016</verification_date>
</DOC>